The Global Fractional Flow Reserve Market is expected to reach $ 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period (2019–2024)
Growth in this market is primarily attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost-benefits of FFR, and the presence of a favorable reimbursement scenario.
Download PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=257837023
Fractional Flow Reserve Market segmentation:
· based on technology
· based on the type
· based on application
· based on regions
The Major Players Operating in the Fractional Flow Reserve Market:
The key players in the fractional flow reserve market are Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands).
Abbott (US) held the leading position in the fractional flow reserve market. The company acquired a significant share in the FFR market through the acquisition of St. Jude Medical (US). This acquisition positioned Abbott as a major cardiology devices provider. The strategic acquisition of St. Jude Medical, a leading player in the cardiovascular and neuromodulation products market, strengthened the position of Abbott in the fractional flow reserve market.
Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=257837023
Key Questions addressed by the report
- Which are the key players in the market, and how intense is the competition?
- Emerging countries present immense opportunities for the growth of fractional flow reserve market. Will this situation persist?
- Which product markets will dominate in the future?
- What are the challenges hindering the adoption of fractional flow reserve solutions?
Geographical Detailed Analysis for Fractional Flow Reserve Market:
North America dominated the fractional flow reservemarket in 2018. The large share of the North American fractional flow reserve market can primarily be attributed to the high healthcare spending in the region, rising prevalence of CVD and lifestyle diseases, growth in the geriatric population, large number of ongoing research activities and product launches, availability of reimbursements, and the rapid adoption of technologically advanced imaging systems.
